君实生物 (688180.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(君实生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 1,502,549,915.75986,457,567.67669,702,667.07255,154,522.241,453,492,709.831,218,381,861.73946,048,587.10629,519,132.31
 营业利润(元) -2,457,442,353.76-1,580,362,717.66-1,162,291,985.50-633,218,295.88-2,665,914,431.34-1,716,008,666.56-978,816,217.63-377,914,059.91
 利润总额(元) -2,491,694,600.59-1,607,515,370.44-1,176,824,289.32-637,453,868.76-2,677,184,262.29-1,726,857,731.55-989,987,648.49-379,786,903.49
 净利润(元) -2,535,689,297.85-1,555,128,891.35-1,126,329,526.49-639,619,944.79-2,584,077,472.69-1,734,538,953.68-999,435,618.19-421,188,600.59
 归属于母公司股东的净利润(元) -2,283,431,860.25-1,406,818,402.73-997,412,406.48-543,432,303.73-2,388,049,884.64-1,594,729,564.22-912,405,010.11-396,395,486.59
盈利能力:
 销售毛利率(%) 64.0065.8562.3566.4965.3064.9367.5973.84
 销售净利率(%) -168.76-157.65-168.18-250.68-177.78-142.36-105.64-66.91
 净资产收益率(%) -27.45-19.24-12.77-6.49----
 总资产报酬率ROA(%) -21.41-15.71-11.25-5.65----
 投入资本回报率ROIC(%) -23.20-13.85-9.67-5.16-24.82-19.52-11.01-4.72
营运能力:
 存货周转率(次) 0.950.520.420.16----
 应收账款周转率(次) 4.173.011.900.78----
 总资产周转率(次) 0.130.090.060.02----
偿债能力:
 资产负债率(%) 35.4628.0425.4223.5522.1527.9423.8424.21
 股东权益比率(%) 63.0569.6072.1073.7775.5268.4272.1171.07
 已获利息倍数(倍) 38.1430.0528.9243.8034.0725.2124.1459.64
 流动比率 2.283.133.493.874.092.613.352.93
 速动比率 1.962.562.993.323.602.092.702.45
发展能力:
 营业收入增长率(%) 3.38-19.04-29.21-59.47-63.89-55.18-55.26-61.02
 营业利润增长率(%) 7.827.90-18.74-67.56-377.53-494.71-953.15-180.86
 税后利润增长率(%) 4.3811.78-9.32-37.09-231.26-306.69-9,861.53-205.06
 净资产增长率(%) -24.5923.0219.1414.9619.36-14.78-11.3824.39
 总资产增长率(%) -9.6820.9419.1510.7513.81-0.11-1.4128.07

前瞻产业研究院